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Abstract
The purpose of this research was to produce multi-dimensional scaffolds containing
biocompatible particles and ﬁbres. To achieve this, two techniques were combined and used: T-
Junction microﬂuidics and electrohydrodynamic (EHD) processing. The former was used to
form layers of monodispersed bovine serum albumin (BSA) bubbles, which upon drying formed
porous scaffolds. By altering the T-Junction processing parameters, bubbles with different
diameters were produced and hence the scaffold porosity could be controlled. EHD processing
was used to spray or spin poly(lactic-co-glycolic) (PLGA), polymethysilsesquioxane (PMSQ)
and collagen particles/ﬁbres onto the scaffolds during their production and after drying. As a
result, multifunctional BSA scaffolds with controlled porosity containing PLGA, PMSQ and
collagen particles/ﬁbres were obtained. Product morphology was studied by optical and scanning
electron microscopy. These products have potential applications in many advanced biomedical,
pharmaceutical and cosmetic ﬁelds e.g. bone regeneration, drug delivery, cosmetic cream lathers,
facial scrubbing creams etc.
S Online supplementary data available from stacks.iop.org/BF/6/045010/mmedia
Keywords: electrohydrodynamic, microﬂuidic, scaffolds, microbubbles, particles, ﬁbres,
biomedical
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1. Introduction
Scaffolds play an important role in tissue engineering by acting
as porous biodegradable structures containing various bio-
products (cells, genes, drugs and proteins) [1–4]. They serve as
surrogate matrices, e. g. extra cellular (ECM) and can be pro-
duced from natural or synthetic material or a combination of both
[5, 6]. In order for scaffolds to mimic the function of the natural
ECM available in the human body, they must balance mechan-
ical function with transport of bioactive agents [7, 8]. While a
denser scaffold offers better function and mechanical strength, a
more porous scaffold enables greater diffusion of gas/liquid
components and promotes cell growth [6].
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Many techniques have been developed for the prepara-
tion of these porous matrices, including particle leaching [9],
freeze drying [10], phase separation [11], electrospraying
[12], and electrospinning [13] and recently bioprinting [14].
Scaffolds produced by these methods have pores with a wide
size and shape distribution leading to insufﬁcient transport of
nutrition, migration and attachment of cells. Moreover, the
use of organic solvents and particulate leaching in most of
these techniques reduce the biocompatibility of the structure
which hinders the growth of cells [15]. In order to create
favourable scaffold environments the base material should
have a suitable decomposition rate, good biocompatibility and
surface characteristics and favourable plasticity [16]. Biode-
gradable materials from natural polymers such as hyaluronic
acid, alginate and chitosan to synthetic polymers such as poly
(L-lactic acid) (PLA) and poly (L-lactic-co-glycolic acid)
(PLGA), are commonly used for the fabrication of scaffolds
and have been extensively researched [17]. However, most
polymeric scaffolds are hydrophobic and this discourages cell
attachment and growth. In order to address this problem many
methods have been suggested such as coating the scaffold
with proteins or soaking it in various growth factors via
spontaneous adsorption or covalent linking [18]. While these
additional treatment methods assist with cell attachment and
growth in polymeric matrices, they may also alter the mor-
phological and physical properties of the scaffolds [19].
Recently bovine serum albumin (BSA) microbubbles
have been used as porogens with low toxicity and high bio-
compatibility to fabricate scaffolds [20]. In addition to
improvement in the porosity of scaffolds, albumin micro-
bubbles can shield encapsulated growth factors from solvent
denaturation. Nair et al [19] used a sonication technique to
produce BSA microbubbles and fabricated scaffolds by phase
separation of a polymer solution mixed with microbubbles.
Microbubbles produced using the sonication technique gen-
erally have a wide size distribution and therefore the scaffolds
produced with this method were not homogeneous. An
alternative to this method is to use a microﬂuidic technique,
whereby emulsions and foams characterized by monodisperse
droplet/bubble sizes can be readily prepared. These systems
could be used to generate porous materials with a highly
consistent pore size [21, 22]. Microﬂuidic devices offer an
unparalleled level of control over microbubble/droplet size
and size distribution [23, 24]. Chiu et al [25] applied
microﬂuidic techniques to generate gelatine microbubbles and
incorporated them into scaffold structures in the micro-
channel. Colosi et al [26] used a microﬂuidic foaming tech-
nique for the generation of highly monodisperse gas-in-liquid
poly(vinyl alcohol) (PVA) bubbles as a template for a scaf-
fold characterized by an ordered and homogeneous porous
texture.
In addition to microbubbles, particles containing growth
factors have been incorporated into porous scaffolds [27].
Encapsulation of drugs into polymeric microparticles, and
subsequent injection, is a proven method of controlled
delivery for bioactive agents [28]. Electrohydrodynamic
(EHD) processing can produce uniform solid and encapsu-
lated particles and ﬁbres with diameters ranging from a few
nanometres to several micrometres in a single step, under
ambient conditions, at low cost and without the need for high
concentrations of additives or surfactants [29, 30]. Moreover,
multifunctional products (particles/ﬁbres) loaded with ther-
apeutic compounds (drugs, growth factors, DNA etc) can be
generated via co-axial electrohydrodynamic processing
(CEHD) [31]. However, there are limitations to incorporating
polymeric particles/ﬁbres into polymeric scaffolds due to the
simultaneous equivalent solubility of the particles and scaf-
folds. Alternatively, protein-engineered biomaterials have the
advantage of being able to combine desirable biocompat-
ibility properties of natural ingredients with those of synthetic
structures [32]. Proteins are complex organic macromolecules
with an inhomogeneous charge distribution that results in
amphiphilicity, structural ﬂexibility and bioactivity, and
therefore play a signiﬁcant role in reinforcement, structuring
and functionalization of ceramics and tissue engineering
scaffolds [33, 34].
In this study we present a novel method that combines
microﬂuidics with EHD processing to produce porous BSA
scaffolds from microbubble templates with functional parti-
cles and/or ﬁbres incorporated into the scaffolds’ structure.
The porosity and the size of the structures were controlled by
adjusting the processing parameters of the microﬂuidic
device. PLGA, PMSQ and collagen particles/ﬁbres were then
sprayed on them using the EHD technique. These secondary
elements in the assembly of scaffolds can assist with the
mechanical strength of the structure as well as providing a
suitable route to deliver drugs and growth factors. The hybrid
fabrication technique combines the high degree of control
over size and size distribution offered by microﬂuidics to
control pore size, with the efﬁciency of the electrospraying
process for ﬁbre generation. As with other electro-
hydrodynamic techniques it also offers excellent encapsula-
tion efﬁciency for functional components, a low number of
processing steps and the potential to apply the technique to a
wide range of materials.
2. Materials and methods
2.1. Materials
Poly(lactic-co-glycolic) acid (PLGA co-polymer 50:50,
Resomer RG503H, molecular weight: 33000 g mol−1) was
purchased from Boehringer Ingelheim, (Ingelheim, Ger-
many). Acetone, ethanol, collagen (Type I solution from rat
tail in acetic acid), Tween 40, phosphate buffer saline (PBS),
L-α-Phosphatidylcholine hydrogenated (phospholipid) and
bovine serum albumin (BSA, molecular weight:
66 000 g mol−1) were purchased from Sigma Aldrich (Poole,
UK). Polymethysilsesquioxane (PMSQ) with an average
molecular weight of 7465 g mol−1 was obtained from Wacker
Chemie AG, GmbH (Burghausen, Germany). Acetone and
ethanol were used as solvents to prepare 5% w/w PLGA and
12% w/w PMSQ solutions, respectively, by dissolving them
with magnetic stirrers in separate volumetric ﬂasks until a
homogenous suspension was formed. The collagen solutions
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were prepared by adding the as received material into PBS
solution and had a concentration of 8% and 15% v/v. Sub-
sequently, the ﬁnal solutions were vortexed for 120 s.
2.2. Characterization of solutions
The polymer solutions were characterized to determine their
density, surface tension, viscosity, electrical conductivity and
pH. Density was measured using a standard 25 ml density
bottle. A Kruss tensiometer was used to measure the surface
tension (standard Wilhelmy’s plate method) and a U-Tube glass
viscometer suitable for low viscosities (VWR International Ltd,
Lutterworth, UK) was used to measure the viscosity of each
solution. The electrical conductivity and pH of the solutions
were determined using a Jenway 3540 pH/conductivity meter
(Bibby Scientiﬁc Limited, Stone, UK). All the instruments were
calibrated before use by following the manufacturers calibration
guide and all experiments were performed at the ambient
temperature of 25 °C, ambient pressure (101.3 kPa), and relative
humidity (45–60%). Table 1 shows the measured liquids’
physical properties used for the experiments.
2.3. Experimental setup
The experimental setup for producing the bubble/particle and
bubble/ﬁbre products is shown in ﬁgure 1. It consists of a
single brass EHD needle device (inner diameter: 1.35 mm,
outer diameter: 1.82 mm), a microﬂuidic T-Junction device
(two entry ports and an exit port), two ‘PhD 4400’ high
precision syringe pumps (Harvard Apparatus Limited, Eden-
bridge, UK) to control the ﬂow rate of the solutions to one of
the entry ports of the T-Junction device and to the EHD
needle, a high precision voltage generator connected to the
EHD needle (Glassman Europe Limited, Bramley, UK) and a
gas supply cylinder, which transports air at high pressure into
the secondary T-Junction entry port. Three ﬂuorinated ethy-
lene propylene (FEP) capillary tubes with internal diameter of
200 micrometre were inserted in a polydimethylsiloxane
(PDMS) block to form the channels of the T-Junction set-up
(more detail on the setup and schematic can be found in
reference [35]). A 10 ml volume capacity Becton-Dickinson
(Becton and Dickinson Company, Oxford, UK) syringe
containing the 15% w/w BSA solutions was loaded to one of
Table 1. Physical properties of liquids used in experiments. All % refer to weight unless stated otherwise.
Material or polymer
solution
Density
(kg m−3) Viscosity (mPa s)
Surface ten-
sion (mN m−1)
Electrical con-
ductivity ( μS m−1) pH
BSA 15% 1070 ± 20 1.62 ± 0.03 51.4 ± 0.1 6.44 ± 0.01 (x106) 6.71 ± 0.01
PLGA 5% 780± 10 0.78 ± 0.03 22.2 ± 0.2 339 ± 6 5.43 ± 0.06
PMSQ 12% 810 ± 10 1.04 ± 0.02 22.3 ± 0.2 730 ± 2 4.13 ± 0.06
Collagen 15% v/v 1060 ± 30 1.19 ± 0.02 51.6 ± 0.4 4.24 ± 0.02 (x106) 6.53 ± 0.02
Collagen 8% v/v 620 ± 20 0.76 ± 0.03 37.6 ± 0.4 3.62 ± 0.02 (x106) 5.64 ± 0.04
Figure 1. Schematic illustration of the T-Junction/EHD setup used for the experiments.
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the syringe pumps and a silicone tube was used to transfer it
to one of the T-Junction entry ports. The other syringe pump
was loaded with a 10 ml syringe ﬁlled with a different solu-
tion at each time (PLGA, PMSQ and collagen) and a silicone
tube was used to transfer these to the EHD needle.
2.4. Formation of bio-products
The processing conditions were optimised to form uniform
and reproducible products in micro and nano scale dimen-
sions, as described below:
(Video clips showing the different procedures used are
included in the supplementary information provided.)
2.4.1. Bubbles. The T-Junction device was used to obtain the
bubbles providing the scaffold template. Three different solutions
of BSA 15% w/w were used to produce the bubbles: BSA,
BSA+Tween 40 (90%/10%) and BSA+phospholipid solution
(50%/50%). Air was used in all cases as the gas phase. Following
bubble production, the most stable ones (assessing them by the
number of bubbles bursting in time) before and after drying were
chosen for the experiments. The bubble diameter was controlled
by changing the air pressure and liquid ﬂow infused to the T-
Junction device. The processing conditions were optimised to
generate monodispersed bubbles for each experiment. The
working distance between the T-Junction needle tip and the
collector (glass slide) was set to 120mm. Once the bubbles were
collected on glass slides, they were left to dry at ambient
temperature and pressure.
2.4.2. Particles. The EHD process was used to produce
polymeric particles. The processing conditions (ﬂow rate,
voltage) were optimised to form particles in nano and sub-micro
scale in order to increase their density per mm2 on the bubbles’
surfaces. To achieve this, EHD parameters were optimised to
obtain a stable cone-jet at the EHD needle tip [36, 37].
2.4.2.1. PLGA. To produce the PLGA particles the voltage
was set to 11 kV and the ﬂow rate of the PLGA solution was
ﬁxed at 20 μl min−1. The working distance between the needle
tip and the collector (glass slide) was set to 120 mm and the
distance between the EHD needle and the T-Junction tip was
set at a distance of 50 mm. The EHD needle was set at an
angle of 45° (Reference Angle (RA): At 0° if the EHD needle
was set at a vertical position with its nozzle facing the ground)
in order to spray directly onto the bubbles that were produced
from the T-Junction process.
2.4.2.2. PMSQ. To produce the PMSQ particles the voltage
was set to 9 kV and the ﬂow rate of the PLGA solution was
ﬁxed at 10 μl min−1. All the other parameters remained the
same as in the PLGA particles production experiment.
2.4.2.3. Collagen. Collagen solution 8% v/v was used to
form the particles. The voltage was set to 14 kV and the ﬂow
rate of the collagen solution was ﬁxed at 5 μl min−1. All the
other parameters remained the same as in previous
experiments.
2.4.3. Collagen beaded nanofibres. To form collagen ﬁbres,
a solution of 15% v/v collagen was used and the applied
voltage was set to 21 kV. The ﬂow rate of the collagen
solution was ﬁxed at 3 μl min−1. All the other parameters
remained the same as in the previous experiments. In this
study beading was deliberately exploited as a means of
increasing the volume of material into which a functional
component can be incorporated.
2.5. Combination of bio-products
After the production of the BSA bubbles two different
experimental approaches were followed to spray the second-
ary bio-products onto the bubbles: a) when the bubbles were
produced by the T-Junction process, the secondary bio-pro-
ducts formed by the EHD process were simultaneously
sprayed directly on them (ﬁgures 1a and b) the bubbles/
scaffolds were left to dry after their production and then the
secondary bio-products were sprayed on them.
2.6. Product characterization
The bubbles/scaffolds, particles, ﬁbres and the combined
structures were analysed for their diameter and surface mor-
phology by optical microscopy (Micropublisher 3.3 RTV, 3.3
megapixel CCD Color-Bayer Mosaic, Real Time Viewing
camera, MediaCybernetics, Marlow, UK) and scanning
electron microscopy (Hitachi S-3400N and JEOL JSM-6301F
ﬁeld emission scanning electron microscopes, SEM). The
bubbles, bubble/particle and bubble/ﬁbre structures were
collected and studied by optical microscopy immediately and
after 15 and 30 min after production to detect any changes in
their size and morphology. Then they were left to dry for 12 h
and then studied by scanning electron microscopy at an
acceleration voltage of 3–5 kV. All the samples were vacuum-
coated with gold for 120 s before obtaining SEM images.
Analysis of the products was carried out using the Image-Pro
Insight software (MediaCybernetics Ltd, Marlow, UK).
3. Results and discussion
3.1. Bubble formation
After the bubbles were produced they were monitored for
their stability (number of bubbles bursting as time progressed
and how long they need to dry in order to obtain a solid
scaffold). The most stable bubbles were the BSA bubbles
obtained without the addition of any surfactants or phos-
pholipids. Hence the experiments were continued with the
BSA solution only. It is well known that by adjusting the T-
Junction processing parameters (solution concentration, gas
pressure, liquid ﬂow and capillary diameter size) bubbles of
different size can be generated [35]. In this study, BSA
bubbles ranging from ∼80 μm to ∼550 μm were produced by
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keeping the liquid ﬂow rate constant at 200 μl min−1, while
increasing the gas pressure from 30 to 100 kPa. Examples of
the bubbles produced are shown in ﬁgure 2 with images (a)
and (b) showing bubbles having an average diameter of
251 ± 2 μm and 408 ± 4 μm, respectively. Table 2 shows the
parameters used to obtain the different bubble diameters.
3.2. Scaffold structure
The bubbles produced from the T-Junction process had a
foam like texture, hence to produce the multi-layered BSA
scaffolds the bubbles were left to dry for a short period of
time (20 min–60 min) before being sprayed onto. Figure 3
shows the BSA bubbles immediately after generation and at
different time intervals while drying. The bubbles in this case
had an average size of 81 ± 2 μm.
3.2.1. Single layer structure. By collecting a single layer of
BSA bubbles on a glass slide and leaving it to dry for 20 min
a single layer honeycomb arrangement with approximately
the same diameter scaffold window was obtained. Figure 4
shows these structures with a(i) and b(i) having average
window diameters of 152 ± 7 μm and 208 ± 8 μm, respectively
and the images [(a, b)ii] showing the same structures at higher
magniﬁcation. The depth of the windows was found to be
100 ± 9 μm almost ½ the pore diameter and the interconnected
regions of the dried bubbles had an average thickness of
30 ± 9 μm.
3.2.2. Double layer structure. By changing the T-Junction
parameters, the bubbles’ size was increased and a two layered
structure was obtained by adding another layer on the top of a
single layer of bubbles instantly after collection on the glass
slide. The structure was also left to dry for 20 min and after
analysis it was found that the windows formed had an average
diameter of 190 ± 8 μm. Figure 5 shows images of the two
layered structure taken by optical microscope and SEM with
ﬁgure 5(a) clearly showing the double layered arrangement.
Figure 2. BSA bubbles produced from the T-Junction.
Table 2. Parameters used to generate bubbles and their stability. (The bubble-diameter value is the mean diameter of 50 bubbles.)
Solution Air pressure (kPa) Liquid ﬂow (μl min−1) Bubble diameter (μm) Stability
32.3 200 81 ± 2
34.9 200 95 ± 2
41.2 200 141 ± 3
42.7 200 152 ± 4
44.3 200 162 ± 3
45 200 164 ± 3
BSA 46.1 200 174 ± 4 Stable until dried
48.3 200 190 ± 4
51.6 200 208 ± 4
57.3 200 251 ± 2
75 200 302 ± 2
81 200 418 ± 4
92 200 478 ± 2
103.5 200 555 ± 3
BSA+Phospholipid 53 200 245 ± 5 Unstable, burst prior to drying
75 200 285 ± 5
BSA+Tween 40 1100 200 82 ± 4 Unstable, burst prior to drying
1200 200 95 ± 4
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The thickness of the two layer structure formed had an
average value of 342 ± 11 μm.
3.2.3. Multilayer scaffold. After experimenting with the single
and double layered structures, scaffolds were formed by
accumulating many layers of bubbles. By adjusting the T-
Junction processing parameters, mainly increasing the gas
pressure to control the bubble size and collecting multiple
layers of bubbles on a glass slide or a glass vial, 3D scaffolds
with different window sizes and hence porosity, were produced.
The BSA bubbles spontaneously self-assembled into liquid foam
structures, which were solidiﬁed after leaving to dry for 60min.
During the drying process, the pressure difference between the
bubbles and the ambient atmosphere ruptured the ﬁlm between
the bubbles and only the plateau borders were left. The dried
foam formed 3D scaffolds and by adjusting the T-Junction
processing parameters four different structures were obtained
with window diameters of 162±17 μm, 327±24 μm,
478±28 μm and 543±33 μm obtained at various gas pressures
of 44, 67, 93 and 102 kPa, respectively. Figure 6 shows these
scaffolds with ﬁgure 6(a) having the biggest pore size and
ﬁgure 6(d) the smallest. The ﬁgures indicate the ordered and
interconnected pores of the 3D scaffolds. It was noticed that
despite the monodispersity of the bubbles formed during the
process the diameter size distribution of the scaffolds pores was
broader in the multi-layered scaffolds than in the single and
double layered structures obtained at the previous experiments.
This can also be conﬁrmed from the relatively large standard
deviation values measured (17, 24, 28 and 33) during the scaffold
pore size analysis. This was probably caused by the increased
pressure due to the weight of the bubbles located on the top
layers acting on the bubbles in the lower layers. However, the
pore size of the scaffolds produced in this study with the T-
Junction process still had a narrower size distribution than other
techniques used to fabricate scaffolds. It was also noticed in some
cases that when the BSA bubbles were bursting during the drying
process a thin cracked layer of protein coating was left at the
sides of the scaffolds gaps. According to Nair et al [19] this thin
protein coating may serve as a biocompatible layer to promote
cell seeding and growth.
3.3. Particles sprayed on bubbles
The ﬁrst experimental approach was to spray the bio-particles
formed by the EHD process onto the BSA bubbles generated
via the T-Junction process simultaneously. In this procedure
the stability of the bubbles was affected by the particles
Figure 3. Optical microscope images of BSA bubbles: (a) 1 min, (b) 10 min, (c) 15 min and (d) 20 min after generation.
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accelerated due to the electric potential difference induced by
the EHD process rupturing the bubbles shell and causing
them to burst. Approximately 30% of the bubbles produced
were bursting due to this effect. Although many strategies
were attempted to resolve this, such as adjusting the liquid
ﬂow rate into the EHD needle, increasing the BSA con-
centration and the distance between the EHD needle tip and
the collection area, none had a signiﬁcant effect on the bub-
bles stability. An advantage of this approach, however, was
that the particles were distributed equally in the inner and
outer surfaces of the scaffold while it was formed.
The second experimental approach was to leave the scaffold
to dry and then spray the particles onto it. The advantage of this
method was that the bubbles were left to dry without any external
disturbance and thus the percentage of bubbles bursting
decreased to less than 5%. Also the particles were still able to
inﬁltrate into the scaffolds’ structure very easily because of their
small size, and hence were distributed on the scaffolds’ inner
surfaces. As expected, however the outer surface of the ﬁnal
scaffold had a higher density of particles than the inner ones.
3.3.1. PLGA particles. The bubble and particle sizes used for
this experiment were 141 ± 3 μm and 130 ± 23 nm (mean
diameter of 100 particles), respectively. Firstly, PLGA
particles were sprayed onto wet (not dried) bubbles
(ﬁgures 7(a) and (b)) and then PLGA particles were sprayed
onto a single layered (ﬁgure 7(c)), two layered (ﬁgure 7(e))
and multi layered (ﬁgure 7(f)) BSA scaffolds.
In order to check if the particles had inﬁltrated into the
inner layers of the BSA scaffold, the surface of the structure
was removed by a surgical blade. Figure 7(c) conﬁrms that
the particles were present on the bottom layer of the scaffold.
Figure 7(d) shows the PLGA particles aggregating into
different shapes while they were sprayed into the inner
cavities of the scaffold. This is caused by the difference in the
hydrophobic and hydrophilic nature of the PLGA and BSA,
respectively [38, 39].
3.3.2. PMSQ particles. The average window diameter of the
multilayered scaffold was measured and found to be
95 ± 41 μm. The PMSQ particles sprayed had an average
size of 1.94 ± 0.4 μm (mean diameter of 100 particles).
Figure 8 shows SEM images of the same BSA scaffold at
different magniﬁcations after being sprayed with PMSQ
microparticles. It can be seen clearly that the particles
Figure 4. SEM images of a single layer of dried BSA bubbles formed on a glass slide with [(a,b)i] showing structures with two different
window diameters controlled by changing the T-Junction parameters and [(a,b)ii] showing the images in [(a,b)i] at higher magniﬁcation.
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inﬁltrated the inner surfaces of the scaffold and were
distributed homogeneously.
3.3.3. Collagen particles. In these experiments the pores of
the scaffold prepared had an average diameter of 174 ± 8 μm
and the collagen particles sprayed on it had a size of
1.35 ± 0.3 μm (mean diameter of 100 particles). Figure 9
shows SEM images at different magniﬁcations of the same
BSA scaffold sprayed with collagen micro-particles. It was
observed that the scaffold surface (see ﬁgure 9(f)) appeared
degraded due to spraying the collagen particles. This was
caused by the low concentration of acetic acid found in the
Figure 5. Double layer dried BSA scaffold structure (a) optical and (b) SEM micrographs.
Figure 6. Scanning electron micrographs of multi-layer scaffolds made using dried BSA bubbles showing the different diameter window sizes obtained
by changing the T-Junction processing parameters (a) having the biggest window diameter (543±33 μm) and (d) the smallest one (162±17 μm).
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collagen type I solution used for the experiments. When the
collagen solution was sprayed onto the scaffold, it is
assumed that the acid did not fully evaporate during the
ﬂight from the EHD needle tip to the collection area
(probably due to its high boiling point of 118 °C), hence
causing the protein based surface of the scaffold to locally
dissolve and the collagen particles to embed into the BSA
scaffold.
Figure 7. Images showing (a) dried BSA bubbles, (b) dried BSA bubbles with PLGA nanoparticles, (c) a single layer BSA scaffold with PLGA
nanoparticles in its cavities after spraying for 1 min (see arrows), (d) PLGA nanoparticles aggregating into different shapes in a BSA scaffold
cavity after spraying for 5 min (e) a two layer BSA scaffold with PLGA nanoparticles and (f) a multilayer BSA scaffold with PLGA nanoparticles.
9
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3.4. Collagen beaded fibres spraying
Collagen beaded ﬁbres with average ﬁbre and bead sizes of
257 ± 25 nm (mean diameter of 100 ﬁbres) and 685 ± 67 nm
(mean diameter of 100 beads), respectively, were spun suc-
cessfully onto the outer surface of the dried BSA scaffold,
which had an average pore size of 164 ± 11 μm. Figure 10(a)
shows SEM images at different magniﬁcations of the same
BSA scaffold after being sprayed with collagen beaded
nanoﬁbres for 5 min and ﬁgure 10(b) shows the same scaffold
after spraying on it for 15 min. In this experiment it was not
possible for the ﬁbres to inﬁltrate into the inner structure of
the scaffold due to their length. Although an attempt was
made to spin the ﬁbres simultaneously while the bubbles were
produced from the T-Junction device, the bubble stability and
self-assembly properties were affected thus causing the scaf-
fold formation to fail.
4. Possible applications
The BSA scaffolds with secondary bio-products attached to
them have potential applications in tissue and bone
regeneration engineering, wound care and cosmetics. BSA is
a biocompatible and biodegradable FDA approved material
that is non-toxic and can provide high cell afﬁnity when the
scaffold pore sizes are around 100–150 μm[19]. In this study
it was shown that the porosity of the scaffolds can be very
easily controlled thus providing the necessary structure for
different types of cell to achieve inﬁltration into the scaffold.
The BSA solution can be replaced or combined with other
materials such as hydroxyapatite that can be used for bone
regeneration [40, 41]. The PLGA, PMSQ and collagen
particles/ﬁbres sprayed onto the scaffolds (which can also
have a foam like texture) can be loaded with drugs, growth
factors and other bioactive agents in order to achieve con-
trolled release into locations such as wounds, thus accel-
erating the healing process and preventing infections [5, 42].
They can also be used in the cosmetic industry in the form of
cream lathers and facial scrubbing creams to deliver vita-
mins, proteins and other substances into the skin [43]. The
main advantage of using these biodegradable and bio-
compatible products produced in this work in cosmetics
applications are that they are generally non-reactive when in
contact with the human skin and by encapsulating them in
Figure 8. SEM images at different magniﬁcations showing the same multilayered BSA scaffold after spraying with PMSQ micro-particles
with images (a) and (d) having the lowest and the highest magniﬁcation, respectively.
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the polymeric particles/ﬁbres their biological stability can be
increased [44].
5. Conclusions
In this study T-Junction microﬂuidic and EHD techniques
were combined and used together successfully to engineer
advanced biocompatible scaffolds containing secondary bio-
products in their structure. BSA protein scaffolds with con-
trolled porosity varying from 81 ± 2 μm to 543 ± 33 μm were
produced from microbubbles generated with the T-Junction
technique by adjusting the operating parameters and solution
properties. Once the microbubbles were dried, the 3D protein
scaffold structures were obtained. The microbubbles pro-
duced with the T-Junction technique were highly mono-
dispersed and hence led to the uniformity of the scaffold
structure. Further by using the EHD process, biocompatible
Figure 9. SEM images at different magniﬁcations showing the same multilayered BSA scaffold after spraying with collagen micro-particles
with images (a) and (f) having the lowest and the highest magniﬁcation, respectively.
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PLGA, PMSQ and collagen particles having an average dia-
meter of 130 ± 23 nm, 1.94 ± 0.4 μm and 1.35 ± 0.5 μm,
respectively, were produced and sprayed onto the scaffolds.
Furthermore, beaded collagen nanoﬁbres (ﬁbre size:
257 ± 25 nm and beads size: 685 ± 67 nm) were spun on the
BSA scaffolds. The BSA protein scaffolds with attached
secondary bio-products formed in this work have the potential
to be used as medical and tissue engineering scaffolds, as well
as delivery devices containing multiple bioactive agents. It is
also believed that introducing these secondary elements in the
scaffolds’ assembly can improve with the mechanical strength
of the structure.
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